SEARCH

SEARCH BY CITATION

References

  • Aisen P. S. (2002a) Evaluation of selective COX-2 inhibitors for the treatment of Alzheimer's disease. J. Pain Symptom Manage. 23, S35S40.
  • Aisen P. S. (2002b) The potential of anti-inflammatory drugs for the treatment of Alzheimer's disease. Lancet Neurol. 1, 279284.
  • Blais V. and Rivest S. (2001) Inhibitory action of nitric oxide on circulating tumor necrosis factor- induced NF-kappaB activity and COX-2 transcription in the endothelium of the brain capillaries. J. Neuropathol. Exp. Neurol. 60, 893905.
  • Blais V. and Rivest S. (2004) Effects of TNF-alpha and IFN-gamma on nitric oxide-induced neurotoxicity in the mouse brain. J. Immunol. 172, 70437052.
  • Blais V., Zhang J. and Rivest S. (2002) In altering the release of glucocorticoids, ketorolac exacerbates the effects of systemic immune stimuli on expression of proinflammatory genes in the brain. Endocrinology 143, 48204827.
  • Blasko I., Apochal A., Boeck G., Hartmann T., Grubeck-Loebenstein B. and Ransmayr G. (2001) Ibuprofen decreases cytokine-induced amyloid beta production in neuronal cells. Neurobiol. Dis. 8, 10941101.
  • Brochu S., Olivier M. and Rivest S. (1999) Neuronal activity and transcription of proinflammatory cytokines, IkappaBalpha, and iNOS in the mouse brain during acute endotoxemia and chronic infection with Trypanosoma brucei brucei. J. Neurosci. Res. 57, 801816.
  • Caggiano A. O. and Kraig R. P. (1998) Prostaglandin E2 and 4-aminopyridine prevent the lipopolysaccharide-induced outwardly rectifying potassium current and interleukin-1beta production in cultured rat microglia. J. Neurochem. 70, 23572368.
  • Caggiano A. O. and Kraig R. P. (1999) Prostaglandin E receptor subtypes in cultured rat microglia and their role in reducing lipopolysaccharide-induced interleukin-1beta production. J. Neurochem. 72, 565575.
  • Candelario-Jalil E., Gonzalez-Falcon A., Garcia-Cabrera M., Alvarez D., Al-Dalain S., Martinez G., Leon O. S. and Springer J. E. (2003) Assessment of the relative contribution of COX-1 and COX-2 isoforms to ischemia-induced oxidative damage and neurodegeneration following transient global cerebral ischemia. J. Neurochem. 86, 545555.
  • Candelario-Jalil E., Gonzalez-Falcon A., Garcia-Cabrera M., Leon O. S. and Fiebich B. L. (2004) Wide therapeutic time window for nimesulide neuroprotection in a model of transient focal cerebral ischemia in the rat. Brain Res. 1007, 98108.
  • Claveau D., Sirinyan M., Guay J., Gordon R., Chan C. C., Bureau Y., Riendeau D. and Mancini J. A. (2003) Microsomal prostaglandin E synthase-1 is a major terminal synthase that is selectively up-regulated during cyclooxygenase-2-dependent prostaglandin E2 production in the rat adjuvant-induced arthritis model. J. Immunol. 170, 47384744.
  • Engblom D., Saha S., Engstrom L., Westman M., Audoly L. P., Jakobsson P. J. and Blomqvist A. (2003) Microsomal prostaglandin E synthase-1 is the central switch during immune-induced pyresis. Nat. Neurosci. 6, 11371138.
  • Govoni S., Masoero E., Favalli L., Rozza A., Scelsi R., Viappiani S., Buccellati C., Sala A. and Folco G. (2001) The Cycloxygenase-2 inhibitor SC58236 is neuroprotective in an in vivo model of focal ischemia in the rat. Neurosci. Lett. 303, 9194.
  • Ivanov A. I. and Romanovsky A. A. (2004) Prostaglandin E2 as a mediator of fever: synthesis and catabolism. Front. Biosci. 9, 19771993.
  • Ivanov A. I., Pero R. S., Scheck A. C. and Romanovsky A. A. (2002) Prostaglandin E (2)-synthesizing enzymes in fever: differential transcriptional regulation. Am. J. Physiol. Regul. Integr. Comp. Physiol. 283, R1104R1117.
  • Kamei D., Yamakawa K., Takegoshi Y. et al. (2004) Reduced pain hypersensitivity and inflammation in mice lacking microsomal prostaglandin E synthase-1. J. Biol. Chem. 279, 33 68433 695.
  • Kempermann G. and Neumann H. (2003) Neuroscience. Microglia: the enemy within? Science 302, 16891690.
  • Lacroix S. and Rivest S. (1996) Role of cyclo-oxygenase pathways in the stimulatory influence of immune challenge in the transcription of a specific CRF receptor subtype in the rat brain. J. Chem. Neuroanat. 10, 5371.
  • Lacroix S. and Rivest S. (1997) Functional circuitry in the brain of immune-challenged rats: partial involvement of prostaglandins. J. Comp. Neurol. 387, 307324.
  • Lacroix S. and Rivest S. (1998) Effect of acute systemic inflammatory response and cytokines on the transcription of the genes encoding cyclooxygenase enzymes (COX-1 and COX-2) in the rat brain. J. Neurochem. 70, 452466.
  • Lacroix S., Valliëres L. and Rivest S. (1996) C-fos mRNA pattern and CRF neuronal activity throughout the brain of rats injected centrally with a prostaglandin of E2 type. J. Neuroimmunol. 70, 163179.
  • Laflamme N. and Rivest S. (1999) Effects of systemic immunogenic insults and circulating proinflammatory cytokines on the transcription of the inhibitory factor kappa B alpha within specific cellular populations of the rat brain. J. Neurochem. 73, 309321.
  • Laflamme N., Lacroix S. and Rivest S. (1999) An essential role of interleukin-1β in mediating NF-κB activity and COX-2 transcription in cells of the blood–brain barrier in response to systemic and localized inflammation, but not during endotoxemia. J. Neurosci. 19, 10 92310 930.
  • Li S., Ballou L. R., Morham S. G. and Blatteis C. M. (2001) Cyclooxygenase-2 mediates the febrile response of mice to interleukin-1beta. Brain Res. 910, 163173.
  • Matsumura K., Cao C., Ozaki M., Morii H., Nakadate K. and Watanabe Y. (1998a) Brain endothelial cells express cyclooxygenase-2 during lipopolysaccharide-induced fever: light and electron microscopic immunocytochemical studies. J. Neurosci. 18, 62796289.
  • Matsumura K., Cao C., Ozaki M., Morii H., Nakadate K. and Watanabe Y. (1998b) Electron microscopic evidence for induction of cyclooxygenase-2 in brain endothelial cells. Ann. N Y Acad. Sci. 856, 278280.
  • McGeer P. L., Schulzer M. and McGeer E. G. (1996) Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies. Neurology 47, 425432.
  • Minghetti L. and Levi G. (1998) Microglia as effector cells in brain damage and repair: focus on prostanoids and nitric oxide. Prog. Neurobiol. 54, 99125.
  • Murakami M., Nakatani Y., Tanioka T. and Kudo I. (2002) Prostaglandin E synthase. Prostaglandins Other Lipid Med. 68–69, 383399.
  • Murakami M., Nakashima K., Kamei D., Masuda S., Ishikawa Y., Ishii T., Ohmiya Y., Watanabe K. and Kudo I. (2003) Cellular prostaglandin E2 production by membrane-bound prostaglandin E synthase-2 via both cyclooxygenases-1 and -2. J. Biol. Chem. 278, 37 93737 947.
  • Nguyen M. D., Julien J. P. and Rivest S. (2002) Innate immunity: The missing link in neuroprotection and neurodegeneration? Nat. Rev. Neurosci. 3, 216227.
  • Pompl P. N., Ho L., Bianchi M., McManus T., Qin W. and Pasinetti G. M. (2003) A therapeutic role for cyclooxygenase-2 inhibitors in a transgenic mouse model of amyotrophic lateral sclerosis. FASEB J. 17, 725727.
  • Quan N., Whiteside M., Kim L. and Herkenham M. (1997) Induction of inhibitory factor kBa mRNA in the central nervous system after peripheral lipopolysaccharide administration: An in situ hybridization histochemistry study in the rat. Proc. Natl Acad. Sci. USA 94, 10 98510 990.
  • Rivest S. (1999) What is the cellular source of prostaglandins in the brain in response to systemic inflammation? Facts and controversies. Mol. Psychiat. 4, 501507.
  • Rivest S. (2001) How circulating cytokines trigger the neural circuits that control the hypothalamic–pituitary–adrenal axis. Psychoneuroendocrinology 26, 761788.
  • Salzberg-Brenhouse H. C., Chen E. Y., Emerich D. F. et al. (2003) Inhibitors of cyclooxygenase-2, but not cyclooxygenase-1 provide structural and functional protection against quinolinic acid-induced neurodegeneration. J. Pharmacol. Exp. Ther. 306, 218228.
  • Scali C., Prosperi C., Vannucchi M. G., Pepeu G. and Casamenti F. (2000) Brain inflammatory reaction in an animal model of neuronal degeneration and its modulation by an anti-inflammatory drug: implication in Alzheimer's disease. Eur. J. Neurosci. 12, 19001912.
  • Scali C., Giovannini M. G., Prosperi C., Bellucci A., Pepeu G. and Casamenti F. (2003) The selective cyclooxygenase-2 inhibitor rofecoxib suppresses brain inflammation and protects cholinergic neurons from excitotoxic degeneration in vivo. Neuroscience 117, 909919.
  • Schiltz J. C. and Sawchenko P. E. (2002) Distinct brain vascular cell types manifest inducible cyclooxygenase expression as a function of the strength and nature of immune insults. J. Neurosci. 22, 56065618.
  • Shibata H., Katsuki H., Nishiwaki M., Kume T., Kaneko S. and Akaike A. (2003) Lipopolysaccharide-induced dopaminergic cell death in rat midbrain slice cultures: role of inducible nitric oxide synthase and protection by indomethacin. J. Neurochem. 86, 12011212.
  • Tanioka T., Nakatani Y., Semmyo N., Murakami M. and Kudo I. (2000) Molecular identification of cytosolic prostaglandin E2 synthase that is functionally coupled with cyclooxygenase-1 in immediate prostaglandin E2 biosynthesis. J. Biol. Chem. 275, 32 77532 782.
  • Teismann P. and Ferger B. (2001) Inhibition of the cyclooxygenase isoenzymes COX-1 and COX-2 provide neuroprotection in the MPTP-mouse model of Parkinson's disease. Synapse 39, 167174.
  • Teismann P., Vila M., Choi D. K., Tieu K., Wu D. C., Jackson-Lewis V. and Przedborski S. (2003a) COX-2 and neurodegeneration in Parkinson's disease. Ann. N Y Acad. Sci. 991, 272277.
  • Teismann P., Tieu K., Choi D. K., Wu D. C., Naini A., Hunot S., Vila M., Jackson-Lewis V. and Przedborski S. (2003b) Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegeneration. Proc. Natl Acad. Sci. USA 100, 54735478.
  • Thibeault I., Laflamme N. and Rivest S. (2001) Regulation of the gene encoding the monocyte chemoattractant protein 1 (MCP-1) in the mouse and rat brain in response to circulating LPS and proinflammatory cytokines. J. Comp. Neurol. 434, 461477.
  • Turrin N. P. and Rivest S. (2004) Unraveling the molecular details involved in the intimate control of the immune and neuroendocrine systems: a revised and innovative hypothesis. Exp. Biol. Med. 229, 9961006.
  • Yamagata K., Matsumura K., Inoue W., Shiraki T., Suzuki K., Yasuda S., Sugiura H., Cao C., Watanabe Y. and Kobayashi S. (2001) Coexpression of microsomal-type prostaglandin E synthase with cyclooxygenase-2 in brain endothelial cells of rats during endotoxin-induced fever. J. Neurosci. 21, 26692677.
  • Zhang J. and Rivest S. (1999) Distribution, regulation and colocalization of the genes encoding the EP2- and EP4-PGE2 receptors in the rat brain and neuronal reponses to systemic inflammation. Eur. J. Neurosci. 11, 26512668.
  • Zhang J. and Rivest S. (2000) A functional analysis of EP4 receptor-expressing neurons in mediating the action of PGE2 within specific nuclei of the brain in response to circulating interleukin-1β. J. Neurochem. 74, 21342145.
  • Zhang J. and Rivest S. (2001) Anti-inflammatory effects of prostaglandin E2 in the central nervous system in response to brain injury and circulating lipopolysaccharide. J. Neurochem. 76, 855864.
  • Zhang J. and Rivest S. (2003) Is survival possible without arachidonate metabolites in the brain during systemic infection? News Physiol. Sci. 18, 137142.
  • Zhang Y. H., Lu J., Elmquist J. K. and Saper C. B. (2003) Specific roles of cyclooxygenase-1 and cyclooxygenase-2 in lipopolysaccharide-induced fever and Fos expression in rat brain. J. Comp. Neurol. 463, 312.